# The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs

> **NCT06583369** · NA · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 220 (estimated)

## Conditions studied

- Hand-Foot Syndrome

## Interventions

- **DRUG:** Liangxue ointment（Traditional Chinese Ointment）
- **DRUG:** Urea cream

## Key facts

- **NCT ID:** NCT06583369
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-25
- **Primary completion:** 2025-03-25
- **Final completion:** 2025-03-25
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2024-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06583369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06583369, "The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06583369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*